麻疹暴发经济评估的方法学质量:成本-疾病研究的系统综述
本系统综述检索多个数据库,纳入22项麻疹暴发成本分析或成本-疾病研究,评估其成本核算方法学质量。大多数研究(20/22)未报告所采用的成本核算方法、资源与成本构成识别和测量的分解程度以及估值方法。
要点
- 麻疹暴发成本的主要驱动因素为暴发应对、人员和生产损失。
- 大多数研究(20/22)未报告成本核算方法、资源与成本构成识别和测量的分解程度以及估值方法。
核心结论
- 成本核算方法的质量、透明度和准确性对于这些研究结果的有效性及其在高效分配公共卫生资源和指导麻疹暴发控制策略方面的潜在用途至关重要。
研究设计与样本
- 系统检索EMBASE、MEDLINE(通过PubMed)、Ministério da Saúde虚拟健康图书馆(BVS MS)、NHS经济评估数据库(NHS EED)和NHS卫生技术评估(NHS HTA)(通过评价与传播中心图书馆CRD)、EconLit、SCOPUS和Web of Science,纳入麻疹暴发的成本分析和成本-疾病研究(COI),由两名独立评审员筛选文献并提取数据,使用COI研究关键评价指南评估成本核算方法质量,进行定性叙述性综合。
主要发现
- 共纳入22项研究,多数研究评估的是2011年至2013年和2017年至2019年发生的暴发。
- 麻疹暴发成本的主要驱动因素为暴发应对、人员和生产损失。
- 大多数研究(20/22)未报告所采用的成本核算方法、资源与成本构成识别和测量中使用的分解程度以及资源与成本构成的估值方法。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To identify the main cost components included in the economic evaluations of measles outbreaks, their items and cost drivers, and evaluate the quality of costing methodology, analyzing the key features that may affect the validity of these studies in countries with different income levels. METHODS: We systematically searched multiple databases EMBASE, MEDLINE (via PubMed), Biblioteca Virtual em Saúde do Ministério da Saúde (BVS MS), NHS Economic Evaluation Database (NHS EED) and NHS Health Technology Assessment (NHS HTA) (via The Centre for Reviews and Dissemination Library - CRD), and EconLit, SCOPUS, and Web of Science, selecting cost analysis and cost of illness studies (COI) of measles outbreaks. Two independent reviewers screened articles for relevance and extracted the data. The quality of costing methods was assessed using a guide to critical evaluation of COI studies. We performed a qualitative narrative synthesis. RESULTS: Twenty-two studies were reviewed. Most studies evaluated outbreaks that occurred from 2011 to 2013 and 2017 to 2019. Total costs varied from $40,147 to $39.3 million. Per case cost varied from $168 to $49,439. The main drivers of measles outbreak costs were outbreak response, personnel, and productivity losses. Most studies (20/22) did not report the costing methodology adopted, the degree of disaggregation used in the identification and measurement of resource and costs components and the method for the valuation of resource and cost components. CONCLUSIONS: The quality of the costing methodology, its transparency and accuracy are essential to the validity of these studies results and their potential use to allocate public health resources in the most efficient manner and to inform measles outbreak control strategies, with rapid and effective response.
引用
- de Soarez PC, Martins Rozman L, Siraisi Fonseca T, et al. The methodological quality of economic evaluations of measles outbreaks: A systematic review of cost-of-illness studies. Vaccine. 2023. PMID: 36707337. doi:10.1016/j.vaccine.2023.01.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。